Top Health Tools
Top Health Tools

Top Reports
Top Reports
Top Articles
Top Articles

Top Reviews
Top Reviews
Maximizing Poison Potential: Advisory Panel Calls for Flu Vaccine for Everybody

If you thought only those at risk for of complications should get a yearly flu shot, think again. According to the corrupt officials of the Center For Disease Control's (CDC) advisory panel, everybody should get the flu shot.

The CDC almost certainly will make universal flu vaccination official U.S. policy for this fall's 2010-2011 flu season, as it consistently follows the advice of the panel representatives with strong ties to the pharmaceutical industry such as the Advisory Committee on Immunization Practices (ACIP).

Flu vaccinations will now be advised even for healthy adults ages 19 to 49 who are who are not at highest risk of flu complications and do not come into contact with infants or elderly people.

That's only 15% of the U.S. population. But the ACIP say the effect of the universal recommendation will target far more people. That's because the 19-49 age range will mean more profits and potentially more complications from vaccines which can also lead to even further pharmaceutical intervention.

Under the guise of simplifying confusing guidelines and convincing the public that insurers will cover the flu shots, the panel is using these and other deceptive strategies to promote the universal vaccinations.

ACIP members also said that the universal recommendation would assure Americans that the nation's public health experts (or biggest drug pushers) are fully confident in the safety and effectiveness of the flu vaccine -- particularly the H1N1 swine flu vaccine. If you believe that, I have a nice water front property in the desert to sell you.

Flu vaccines are never tested in humans before they are produced to scale. It doesn't matter what type of flu vaccine it is categorically impossible to test a flu vaccine before it is mass produced on the scale that flu vaccines are manufactured today. It takes several years for most vaccines to move from preclinical development to the marketplace.

Before a vaccine enters human testing, the developer conducts laboratory (in vitro) and laboratory animal (in vivo) testing to determine whether the product will be safe enough for researchers to proceed to clinical trials. If a flu vaccine were to follow the standard development procedures, by the time it would actually enter the marketplace it would be useless, since the strain it was testing against during clinical development has now changed. This is the nature of vaccine development versus flu viruses and something the vaccine industrial complex will never admit to.

The 2010-2011 seasonal flu vaccine will include the H1N1 swine flu virus to ensure a broader segment of population is exposed to the form of the virus. This will maximize the virus' ability to change its receptor bindings, recombine and become far more lethal than its present form. This will also ensure a higher case fatality rate and a much higher rate of infection. As hard as it may be to believe, that is the goal.

Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.

February 26, 2010

This site is owned and operated by 1999-2016. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
volunteerDonateWrite For Us
Stay Connected With Our Newsletter